Top Markets
#1 MowCat MowCat +779.10%
#2 龙虾 (Lobster) 龙虾 (Lobster) +84.18%
#3 Magma Finance Magma Finance +38.31%
#4 Akedo Akedo +38.00%
#5 MarsCoin MarsCoin +31.11%
#6 SIXSEVEN SIXSEVEN +30.85%
#7 Cortex Cortex +25.84%
#8 DeXe DeXe +19.90%
#9 Pons Pons +15.98%
#10 OpenEden OpenEden +14.56%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Clasificación en acciones #7952
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Precio por acción
$3.11
Capitalización bursátil
$1.41B
Cambio (1 día)
-1.97%
Cambio (1 año)
-57.22%
País
CN
Comercio Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Categoría

Healthcare
Historial de dividendos de Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (símbolo bursátil: 300204) realizó un total de 0 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: 0.00
Rentabilidad por dividendo (TTM): 0
Pagos de dividendos de Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204) desde 2026 hasta 2026
Pagos anuales de dividendos
Año Dividendo (ajustado por splits de acciones) Cambiar
Not enough data for the provided dates.
Lista de todos los pagos de dividendos
Año Dividendo Cambiar
Not enough data for the provided dates.
Pagos de dividendos de empresas similares o competidoras
Empresa Número de pagos de dividendos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH